Kevin Pollack Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kevin Pollack.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kevin Pollack. Kevin Pollack is Director in PRESSURE BIOSCIENCES INC ($PBIO) and in MAGNEGAS CORP ($MNGA) and Director in MAGNEGAS CORP ($MNGA) and Chief Financial Officer in OPIANT PHARMACEUTICALS, INC. ($MDRV) and See Remarks in OPIANT PHARMACEUTICALS, INC. ($OPNT) and Director in Taronis Fuels, Inc. ($TRNF).
Latest Insider Trading Transactions of Kevin Pollack
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TRNX, OPNT, PBIO, TRNF
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 01 2021 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Buy | J | 2.08 | 494 | 1,028 | 21,897 | 21.4 K to 21.9 K (+2.31 %) |
Jan 08 2021 | TRNF | Taronis Fuels, Inc ... | Pollack Kevin | Director | Option Exercise | A | 3.69 | 33,875 | 124,999 | 33,875 | |
Dec 11 2020 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Buy | J | 1.55 | 662 | 1,026 | 20,905 | 20.2 K to 20.9 K (+3.27 %) |
Aug 31 2020 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Buy | J | 2.32 | 443 | 1,028 | 20,243 | 19.8 K to 20.2 K (+2.24 %) |
Aug 31 2020 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Buy | J | 2.32 | 443 | 1,028 | 20,243 | 19.8 K to 20.2 K (+2.24 %) |
Jun 10 2020 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Buy | J | 2.45 | 490 | 1,201 | 19,800 | 19.3 K to 19.8 K (+2.54 %) |
May 01 2020 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Buy | J | 1.34 | 742 | 994 | 19,310 | 18.6 K to 19.3 K (+4.00 %) |
Apr 01 2020 | TRNF | Taronis Fuels, Inc ... | Pollack Kevin | Director | Buy | P | 0.09 | 108,696 | 10,000 | 2,736,611 | 2.6 M to 2.7 M (+4.14 %) |
Dec 27 2019 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | A | 0.69 | 52,806 | 36,436 | 52,806 | |
Dec 27 2019 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | A | 0.69 | 17,602 | 12,145 | 17,602 | |
Dec 27 2019 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | D | 3.40 | 17,602 | 59,847 | 0 | |
Dec 10 2019 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Buy | J | 2.77 | 379 | 1,050 | 18,947 | 18.6 K to 18.9 K (+2.04 %) |
Nov 25 2019 | TRNX | TARONIS TECHNOLOGI ... | Pollack Kevin | Director | Grant | A | 1.74 | 384,507 | 669,042 | 525,583 | 141.1 K to 525.6 K (+272.55 %) |
Oct 08 2019 | TRNX | TARONIS TECHNOLOGI ... | Pollack Kevin | Director | Grant | A | 1.72 | 88,719 | 152,597 | 122,132 | 33.4 K to 122.1 K (+265.52 %) |
Aug 21 2019 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Buy | J | 2.83 | 367 | 1,039 | 18,568 | 18.2 K to 18.6 K (+2.02 %) |
Aug 15 2019 | TRNX | TARONIS TECHNOLOGI ... | Pollack Kevin | Director | Grant | A | 0.80 | 93,750 | 75,000 | 260,814 | 167.1 K to 260.8 K (+56.12 %) |
Jul 01 2019 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Buy | J | 3.19 | 322 | 1,027 | 18,201 | 17.9 K to 18.2 K (+1.80 %) |
Jul 01 2019 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Buy | J | 2.03 | 517 | 1,050 | 17,879 | 17.4 K to 17.9 K (+2.98 %) |
Apr 03 2019 | MNGA | TARONIS TECHNOLOGI ... | Pollack Kevin | Director | Grant | A | 0.63 | 166,667 | 105,000 | 166,731 | 64 to 166.7 K (+260,417.19 %) |
Dec 21 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | A | 3.40 | 4,500 | 15,300 | 14,268 | |
Dec 21 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | D | 3.40 | 4,500 | 15,300 | 0 | |
Dec 21 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | A | 3.40 | 3,600 | 12,240 | 9,768 | |
Dec 21 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | D | 3.40 | 3,600 | 12,240 | 0 | |
Dec 21 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | A | 3.40 | 834 | 2,836 | 6,168 | |
Dec 21 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | D | 3.40 | 834 | 2,836 | 0 | |
Dec 21 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | A | 3.40 | 834 | 2,836 | 5,334 | |
Dec 21 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | D | 3.40 | 834 | 2,836 | 0 | |
Dec 21 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | D | 3.40 | 4,500 | 15,300 | 0 | |
Nov 28 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Buy | J | 3.67 | 345 | 1,266 | 17,362 | 17 K to 17.4 K (+2.03 %) |
Sep 19 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Buy | J | 3.27 | 310 | 1,014 | 17,017 | 16.7 K to 17 K (+1.86 %) |
Sep 19 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Buy | J | 4.01 | 316 | 1,267 | 16,707 | 16.4 K to 16.7 K (+1.93 %) |
Jul 20 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | A | 3.40 | 4,500 | 15,300 | 8,100 | |
Jul 20 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | D | 8.40 | 4,500 | 37,800 | 0 | |
Jul 20 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | A | 3.40 | 3,600 | 12,240 | 3,600 | |
Jul 20 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | D | 12.00 | 3,600 | 43,200 | 0 | |
Jul 20 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | A | 3.40 | 3,334 | 11,336 | 3,334 | |
Jul 20 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | D | 9.00 | 3,334 | 30,006 | 0 | |
Jul 20 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | A | 3.40 | 834 | 2,836 | 1,668 | |
Jul 20 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | D | 15.00 | 834 | 12,510 | 0 | |
Jul 20 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | A | 3.40 | 834 | 2,836 | 834 | |
Jul 20 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | D | 15.00 | 834 | 12,510 | 0 | |
Jul 20 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | A | 3.40 | 4,500 | 15,300 | 4,500 | |
Jun 13 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | J | 3.50 | 2,778 | 9,723 | 2,778 | |
Jun 13 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | J | 3.50 | 2,778 | 9,723 | 2,778 | |
Jun 13 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | J | 3.50 | 20,500 | 71,750 | 20,500 | |
Jun 13 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | J | 3.50 | 20,500 | 71,750 | 20,500 | |
Jun 13 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | J | 2.50 | 21 | 53 | 21 | |
Jun 13 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | J | 2.50 | 21 | 53 | 21 | |
Apr 23 2018 | MNGA | MAGNEGAS CORP | Pollack Kevin | Director | Grant | A | 0.78 | 11,004 | 8,583 | 19,792 | 8.8 K to 19.8 K (+125.22 %) |
Mar 28 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Buy | J | 3.32 | 390 | 1,295 | 16,391 | 16 K to 16.4 K (+2.44 %) |
Mar 16 2018 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Buy | J | 4.19 | 309 | 1,295 | 16,001 | 15.7 K to 16 K (+1.97 %) |
Dec 18 2017 | MNGA | MAGNEGAS CORP | Pollack Kevin | Director | Buy | P | 0.29 | 108,334 | 31,417 | 131,813 | 23.5 K to 131.8 K (+461.41 %) |
Nov 27 2017 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Buy | J | 7.66 | 181 | 1,386 | 15,692 | 15.5 K to 15.7 K (+1.17 %) |
Mar 21 2017 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | A | 0.28 | 135,000 | 37,800 | 135,000 | |
Jan 17 2017 | OPNT | OPIANT PHARMACEUTI ... | Pollack Kevin | See Remarks | Buy | P | 6.98 | 4,820 | 33,644 | 4,820 | 0 to 4.8 K |
Dec 06 2016 | MNGA | MAGNEGAS CORP | Pollack Kevin | Director | Buy | P | 0.47 | 21,400 | 10,058 | 234,795 | 213.4 K to 234.8 K (+10.03 %) |
Dec 06 2016 | MNGA | MAGNEGAS CORP | Pollack Kevin | Director | Buy | P | 0.46 | 21,800 | 10,028 | 213,395 | 191.6 K to 213.4 K (+11.38 %) |
Sep 14 2016 | MNGA | MAGNEGAS CORP | Pollack Kevin | Director | Grant | A | 0.62 | 64,516 | 40,000 | 191,595 | 127.1 K to 191.6 K (+50.77 %) |
Jan 05 2016 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | A | 0.40 | 50,000 | 20,000 | 50,000 | |
Jan 05 2016 | PBIO | PRESSURE BIOSCIENC ... | Pollack Kevin | Director | Option Exercise | A | 0.40 | 108,000 | 43,200 | 108,000 | |
Oct 30 2015 | MDRV | OPIANT PHARMACEUTI ... | Pollack Kevin | Chief Financial Off ... | Option Exercise | A | 7.25 | 500,000 | 3,625,000 | 1,580,000 | |
Oct 30 2015 | MDRV | OPIANT PHARMACEUTI ... | Pollack Kevin | Chief Financial Off ... | Option Exercise | A | 8.00 | 200,000 | 1,600,000 | 1,080,000 | |
Oct 30 2015 | MDRV | OPIANT PHARMACEUTI ... | Pollack Kevin | Chief Financial Off ... | Option Exercise | A | 5.00 | 150,000 | 750,000 | 880,000 | |
Oct 30 2015 | MDRV | OPIANT PHARMACEUTI ... | Pollack Kevin | Chief Financial Off ... | Option Exercise | A | 6.00 | 75,000 | 450,000 | 730,000 | |
Oct 30 2015 | MDRV | OPIANT PHARMACEUTI ... | Pollack Kevin | Chief Financial Off ... | Option Exercise | A | 20.00 | 50,000 | 1,000,000 | 655,000 | |
Oct 30 2015 | MDRV | OPIANT PHARMACEUTI ... | Pollack Kevin | Chief Financial Off ... | Option Exercise | A | 15.00 | 50,000 | 750,000 | 605,000 | |
Oct 30 2015 | MDRV | OPIANT PHARMACEUTI ... | Pollack Kevin | Chief Financial Off ... | Option Exercise | A | 10.00 | 165,000 | 1,650,000 | 555,000 | |
Oct 30 2015 | MDRV | OPIANT PHARMACEUTI ... | Pollack Kevin | Chief Financial Off ... | Option Exercise | A | 8.00 | 190,000 | 1,520,000 | 390,000 | |
Jul 06 2015 | MNGA | MAGNEGAS CORP | Pollack Kevin | Director | Grant | A | 0.83 | 12,107 | 10,000 | 127,079 | 115 K to 127.1 K (+10.53 %) |
Mar 25 2015 | MNGA | MAGNEGAS CORP | Pollack Kevin | Director | Grant | A | 0.72 | 13,947 | 10,042 | 114,972 | 101 K to 115 K (+13.81 %) |
Dec 02 2014 | MNGA | MAGNEGAS CORP | Pollack Kevin | Director | Grant | A | 0.83 | 12,107 | 10,049 | 101,025 | 88.9 K to 101 K (+13.62 %) |
Aug 21 2014 | MNGA | MAGNEGAS CORP | Pollack Kevin | Director | Grant | A | 1.17 | 8,554 | 10,008 | 88,918 | 80.4 K to 88.9 K (+10.64 %) |
May 29 2014 | MNGA | MAGNEGAS CORP | Pollack Kevin | Director | Grant | A | 1.27 | 7,837 | 9,953 | 80,364 | 72.5 K to 80.4 K (+10.81 %) |
Apr 08 2014 | MNGA | MAGNEGAS CORP | Pollack Kevin | Director | Grant | A | 0.83 | 12,048 | 10,000 | 72,527 | 60.5 K to 72.5 K (+19.92 %) |
Apr 08 2014 | MNGA | MAGNEGAS CORP | Pollack Kevin | Director | Grant | A | 0.63 | 15,723 | 9,905 | 60,479 | 44.8 K to 60.5 K (+35.13 %) |
Dec 19 2013 | MNGA | MAGNEGAS CORP | Pollack Kevin | Director | Grant | A | 0.76 | 13,245 | 10,066 | 44,756 | 31.5 K to 44.8 K (+42.03 %) |
Dec 19 2013 | MNGA | MAGNEGAS CORP | Pollack Kevin | Director | Grant | A | 1.41 | 7,092 | 10,000 | 31,511 | 24.4 K to 31.5 K (+29.04 %) |
Dec 19 2013 | MNGA | MAGNEGAS CORP | Pollack Kevin | Director | Grant | A | 1.55 | 3,226 | 5,000 | 24,419 | 21.2 K to 24.4 K (+15.22 %) |
Dec 19 2013 | MNGA | MAGNEGAS CORP | Pollack Kevin | Director | Grant | A | 1.38 | 14,493 | 20,000 | 21,193 | 6.7 K to 21.2 K (+216.31 %) |
Oct 11 2012 | MNGA | MAGNEGAS CORP | Pollack Kevin | Grant | A | 0.00 | 6,700 | 0 | 6,700 | 0 to 6.7 K |
Page: 1